1-Pyrrolidinecarboxylic Acid, 3-(2-Aminoethyl)-, Phenylmethyl Ester

1-Pyrrolidinecarboxylic Acid, 3-(2-Aminoethyl)-, Phenylmethyl Ester


    • Product Name 1-Pyrrolidinecarboxylic Acid, 3-(2-Aminoethyl)-, Phenylmethyl Ester
    • Alias (R)-Benzyl 3-(2-aminoethyl)pyrrolidine-1-carboxylate
    • Einecs EINECS 257-528-2
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    197884

    Chemical Formula C14H20N2O2
    Molecular Weight 248.32 g/mol
    Appearance Solid (usually white or off - white)
    Melting Point Data may vary, typical range needs further specification
    Boiling Point Data may vary, typical range needs further specification
    Solubility In Water Low solubility, organic solvents are more suitable
    Solubility In Organic Solvents Soluble in common organic solvents like ethanol, dichloromethane
    Pka Data may vary, needs more specific determination
    Flash Point Data may vary, needs experimental determination
    Odor May have a faint, characteristic odor

    As an accredited 1-Pyrrolidinecarboxylic Acid, 3-(2-Aminoethyl)-, Phenylmethyl Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100 - gram pack of 3-(2 - Aminoethyl)-1 - Pyrrolidinecarboxylic Acid Phenylmethyl Ester.
    Shipping The chemical "1 - Pyrrolidinecarboxylic Acid, 3-(2 - Aminoethyl)-, Phenylmethyl Ester" will be carefully packaged to prevent damage. Shipping will follow strict chemical transport regulations, ensuring safe and timely delivery.
    Storage Store "1 - Pyrrolidinecarboxylic Acid, 3-(2 - Aminoethyl)-, Phenylmethyl Ester" in a cool, dry place away from direct sunlight. Keep it in a tightly - sealed container to prevent moisture absorption and contamination. Store it separately from incompatible substances like strong oxidizing agents or acids to avoid potential chemical reactions.
    Application of 1-Pyrrolidinecarboxylic Acid, 3-(2-Aminoethyl)-, Phenylmethyl Ester
    In the enantioselective synthesis of sitagliptin phosphate monohydrate, the (R)-3-aminoethylpyrrolidine fragment functions as the essential chiral amine coupling partner. The protected building block 1-Pyrrolidinecarboxylic Acid, 3-(2-Aminoethyl)-, Phenylmethyl Ester enables precise regiochemical control during the critical amidation step prior to hydrogenolytic unmasking. A production-scale batch process for this intermediate typically couples the free amine—generated in situ by hydrogenolysis of the Cbz group over 10% Pd/C at 1.0–3.0 bar H₂ in a EtOH:H₂O (4:1 v/v) solvent system at 25–35°C in a Hastelloy C-22 stirred autoclave—with 1.0–1.15 molar equivalents of a pre-activated triazolopyrazine acetic acid derivative (commonly its mixed anhydride formed with pivaloyl chloride or an HOBt-active ester). Residual benzyl alcohol generated during deprotection must be monitored by reverse-phase HPLC at 210 nm to remain below 0.15 area% prior to the acylation step, as carryover alcohol competes with the nucleophilic pyrrolidine nitrogen and generates benzyl ester impurities that are difficult to purge downstream. Full compliance with ICH Q7 GMP for active pharmaceutical ingredient intermediates is required; elemental impurities are controlled per ICH Q3D (particularly Pd ≤ 10 µg/g, Ni ≤ 20 µg/g), and residual solvents are validated against USP <467> Class 2 limits for ethanol (5000 ppm) and Class 3 limits for ethyl acetate when used as extractant. The downstream manufacturing sequence continues with condensation of the resulting amide with a β-ketoester (typically 1.0–1.2 eq. of ethyl 2,4,5-trifluorobenzoylacetate) in the presence of TiCl₄ and pyridine to form the enamine, followed by catalytic asymmetric hydrogenation with a chiral Rh(I)/(S)-Binap catalyst at 40–60°C and 40–70 bar H₂ to set the (3R)-stereocenter with >99.0% ee. The terminal finished dosage form is sitagliptin phosphate monohydrate tablets (eq. to 25, 50, or 100 mg free base) for the management of type 2 diabetes mellitus. Process excursions: if the hydrogenolysis temperature exceeds 50°C, pyrrolidine ring hydrogenation can occur, generating N-Cbz-3-(2-aminoethyl)pyrrolidine contaminants that co-crystallize during final API isolation and must be controlled at <0.10% by a dedicated polar-endcapped C18 HPLC method.
    Comparison of catalytic systems evaluated for selective hydrogenolysis of the Cbz group in 1-Pyrrolidinecarboxylic Acid, 3-(2-Aminoethyl)-, Phenylmethyl Ester (batch scale 50–200 kg)
    CatalystH₂ Pressure (bar)Temperature (°C)Reaction Time (h)Conversion (%)Des-aminoethyl impurity (%)Pd Leaching (µg/g)
    5% Pd/C (Johnson Matthey type 87L)1.5–2.525–304–6>99.80.05–0.123–8
    10% Pd/C (Evonik E101 N/D)1.0–2.030–352–4>99.90.02–0.062–5
    20% Pd(OH)₂ on carbon (Pearlman’s catalyst)2.0–3.520–258–1299.2–99.7<0.03<2

    Why is the Cbz-protected aminoethylpyrrolidine preferred over N-Boc analogues in solution-phase peptide conjugate synthesis?

    When 1-Pyrrolidinecarboxylic Acid, 3-(2-Aminoethyl)-, Phenylmethyl Ester is employed as a non-natural amino acid surrogate in solution-phase peptide coupling, the orthogonal benzyl ester allows for C-terminal protection that remains stable to the acidic conditions (e.g., 20–50% TFA/CH₂Cl₂) used to remove N-Boc groups on other residues, thereby avoiding premature deprotection and oligomerization. In a typical fragment condensation, the Cbz-protected pyrrolidine acid is activated with 1.05–1.30 eq. of isobutyl chloroformate and N-methylmorpholine in anhydrous THF at −15 to −5°C to form the mixed anhydride, then added to a solution of the peptide amine nucleophile (stoichiometry 1.0:0.95 anhydride/amine) to afford the amide linkage within 2–6 h. Residual water in the solvent system must be below 500 ppm (Karl Fischer titration) to prevent anhydride hydrolysis; molecular sieves (3Å) are routinely added. Regulatory compliance for materials destined for injectable peptide therapeutics invokes FDA 21 CFR 210/211 and bacterial endotoxin limits of <0.25 EU/mg per USP <85>. Downstream, the phenylmethyl ester is removed by catalytic transfer hydrogenation (Pd/C, ammonium formate) without disturbing the newly formed peptide backbone, yielding the free acid for subsequent conjugation to a drug-loading linker or PEG polymer. The terminal products include proline-mimetic peptide-drug conjugates and integrin-binding cyclic peptides containing a pyrrolidine turn-inducing element; in preclinical development the pyrrolidine ring restricts backbone flexibility and improves metabolic resistance toward intestinal dipeptidyl peptidases.Using the Cbz aminoethylpyrrolidine scaffold as a versatile chiral amine platform, diversification into targeted libraries of dopamine D3 receptor ligands follows a reductive amination pathway with minimal racemization risk. The unblocked (R)-amine obtained after hydrogenolysis is reacted with a library of aryl aldehydes (1.0–1.2 eq. relative to amine) in dichloroethane containing 1.5–3.0 eq. of sodium triacetoxyborohydride at ambient temperature, furnishing tertiary amines in 70–92% isolated yield and with enantiomeric excess retained above 98.5% when monitored by chiral SFC. This step is typically conducted under a nitrogen atmosphere and free of cyanoborohydride to avoid formation of regulated cyanide by-products. The resulting Cbz-protected tertiary amine intermediates can then be crystallized as hydrochloride salts from MTBE/heptane to chemical purity >98.0% (HPLC, 220 nm). Compliance with ISO 9001:2015 quality management systems is standard for kilo-lab and pilot production of building blocks supplied to CNS drug discovery programs. Process mass intensity (PMI) metrics and residual solvent specifications align with ICH Q3C option 2 limits for dichloroethane (5 ppm) and MTBE (5000 ppm). The terminal deliverables are bi-aryl methylamine tool compounds and back-up series candidates for positron emission tomography (PET) tracer development, where the pyrrolidine ring provides conformational constraint governing subtype selectivity.

    Intermediate for selective cysteine protease inhibitors accessed via Michael acceptors

    Conjugation of the free (R)-3-(2-aminoethyl)pyrrolidine—liberated quantitatively from the Cbz ester by balloon hydrogenolysis with 5% Pd/BaSO₄ in methanol—with a vinyl sulfone warhead proceeds at 0–5°C in acetonitrile containing 2.5 eq. of triethylamine to deliver the covalent inhibitor scaffold. The stoichiometric ratio of the aminoethylpyrrolidine to the sulfonyl chloride intermediate is maintained at 1.00:0.98 to minimize bis-adduct impurities that form when excess sulfonylating agent reacts with the pyrrolidine nitrogen. Post-quench with aqueous sodium bicarbonate and extraction into dichloromethane yields the Cbz-deprotected vinyl sulfone which, after silica gel chromatography (eluent: CH₂Cl₂/MeOH 95:5), is obtained with 82–88% recovery and sulfonate ester impurity <0.3% (LC-MS). The manufacturing operations are governed by occupational exposure limits for acrylate-type Michael acceptors as defined under REACH and local OSHA airborne threshold limit values; all isolations must be performed in contained filter-dryers with nitrogen inertisation. The downstream synthetic route couples this amine-vinyl sulfone with a dipeptide aldehyde intermediate prepared separately, using a 1.05 eq. of EDC/HOBt in DMF to form the amide, followed by global deprotection with TFA/TIS/H₂O (95:2.5:2.5) to release the crude inhibitor. The terminal product class includes reversible-covalent inhibitors of cathepsin B and cathepsin L, intended for oncology indications, where precise loading of the pyrrolidine core influences off-rate kinetics as measured by surface plasmon resonance. Processing shutdown triggers are activated if the exotherm during vinyl sulfone formation exceeds ΔT=12°C within the first 15 min, as this indicates runaway alkylation of the pyrrolidine ring.
    Free Quote

    Competitive 1-Pyrrolidinecarboxylic Acid, 3-(2-Aminoethyl)-, Phenylmethyl Ester prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    In the assembly of complex pyrrolidine-based pharmacophores, the identity of the carbamate protecting group on the endocyclic nitrogen often dictates the efficiency of the entire synthetic sequence. Benzyl 3-(2-aminoethyl)pyrrolidine-1-carboxylate—systematically named 1-pyrrolidinecarboxylic acid, 3-(2-aminoethyl)-, phenylmethyl ester—serves as a bifurcated building block in which the primary aliphatic amine at the C3 substituent remains free for coupling, reductive amination, or sulfonylation, while the pyrrolidine nitrogen is masked as a benzyl carbamate (Cbz). This particular substitution pattern is encountered in intermediates for T-type calcium channel blockers, tryptase inhibitors, and constrained diamine scaffolds targeting bacterial topoisomerases. Routine supply specifications require an HPLC purity threshold of ≥98.0% (area percent, detection at 220 nm, C18 column, acetonitrile/0.1% TFA gradient) and a residual solvent profile compliant with ICH Q3C Option 2 limits, with ethyl acetate typically held below 5000 ppm and dichloromethane below 600 ppm. The neat compound is obtained as a pale-yellow to colorless viscous oil with a density of approximately 1.13 g/cm³ at 20 °C and a molecular weight of 248.32 g·mol⁻¹ (C₁₄H₂₀N₂O₂).

    Why Is Orthogonal Protection of the Pyrrolidine Nitrogen Critical in Late-Stage Functionalization?

    When the target molecule contains additional benzyl ethers or benzylamines, simultaneous hydrogenolysis of the Cbz group introduces a selectivity conflict that can cap isolated yields below 40%. In such cases, the phenylmethyl ester is deliberately chosen over a tert-butyl carbamate (Boc) on the pyrrolidine precisely because the benzyl carbamate survives the acidic conditions commonly used to remove Boc—trifluoroacetic acid in dichloromethane (20–50% v/v) at 0–25 °C—whereas Cbz cleavage requires hydrogen gas (1–4 bar) in the presence of palladium on carbon (5–10% wt, wet or dry) in a protic solvent such as methanol or ethanol. This orthogonal pair enables the sequential liberation of the endocyclic amine without disturbing an exocyclic Boc-protected ethylamine that may be present in a differentially protected analog. In continuous-flow hydrogenation reactors equipped with a H-Cube Pro™ or equivalent fixed-bed catalyst cartridge, complete debenzylation of benzyl 3-(2-aminoethyl)pyrrolidine-1-carboxylate is achieved with residence times of 30–90 seconds at 25 °C and 1 atm hydrogen pressure, delivering the free pyrrolidine intermediate in quantitative conversion as monitored by inline ReactIR. However, when the hydrogenation feed stream contains thioether or alkyne functionalities, competing catalyst poisoning or over-reduction has been documented; in such scenarios, transfer hydrogenation with ammonium formate (4–6 eq) and 10% Pd/C in methanol at 60 °C provides a robust alternative, though filtration through a 0.2 µm PTFE membrane followed by aqueous workup is mandatory to reduce residual palladium below the 10 µg/g threshold specified in the draft ICH Q3D guideline for oral drug substances. In the absence of a packed-bed flow apparatus, batch hydrogenation on a 200-litre scale stirred autoclave (glass-lined, Hastelloy C-22 impeller) at 2 bar H₂ and 25–30 °C has been reported to achieve full Cbz removal after 4–6 hours using 5% Pd/Al₂O₃ ( 5 wt% loading relative to substrate) in isopropanol, with in-process control by TLC (silica, ninhydrin stain). The primary operational risk during the scaled batch process is an exotherm upon catalyst wetting; therefore, the substrate solution is introduced first, and the catalyst slurry is added in three equal portions at 15-minute intervals while maintaining jacket temperature at 20 °C and stirring at 250 rpm. Reported batch-to-batch variance in isolated yield—ranging from 87% to 96%—has been traced to variations in the water content of the incoming isopropanol (Karl Fischer titration, ASTM E203); anhydrous solvent (<0.05% H₂O) is required to prevent solvolysis of the carbamate to the free amine during extended stirring.

    Residual Palladium Clearance and Downstream API Purity Risks

    The direct product of Cbz deprotection, when carried forward into a palladium-catalyzed cross-coupling step such as Buchwald-Hartwig amination, necessitates a metal scavenging sequence that does not deactivate the subsequent catalyst system. Treatment of the crude debenzylated amine with 3 equiv of trimercaptotriazine (TMT) silica-based scavenger (Si-TMT, 1.2 mmol/g loading) in tetrahydrofuran for 2 hours at 50 °C, followed by filtration and charcoal treatment (Darco G-60, 10 wt%), reduces residual palladium from 800–1500 ppm to <5 ppm as quantified by ICP-MS. Failure to implement this scavenging protocol prior to a subsequent Heck coupling has, on pilot-plant records, resulted in an uncontrollable exotherm and formation of regioisomeric impurities exceeding 3.5 area% that co-elute with the desired product under standard reversed-phase HPLC conditions (XBridge C18, 5 µm, 250 × 4.6 mm, gradient 10–90% MeCN in 0.1% H₃PO₄ over 25 min). When benzyl 3-(2-aminoethyl)pyrrolidine-1-carboxylate is instead utilized as an intermediate for constructing a guanidine moiety via reaction with N,N'-di-Boc-S-methylisothiourea, the free ethylamine must be sufficiently nucleophilic under mildly basic conditions. In anhydrous N,N-dimethylformamide with 1.1 equiv of the thiouronium salt and 2.5 equiv of N,N-diisopropylethylamine, full conversion is typically observed within 12 hours at 22 °C (monitored by LCMS at m/z 479.2 [M+H]⁺ for the bis-Boc guanidine adduct). The presence of even 0.5% water in the DMF decreases the reaction rate constant by an order of magnitude, a limitation traced to hydrolysis of the activated thiouronium reagent, and mandates the use of freshly activated molecular sieves previously dried at 300 °C under vacuum (10⁻² mbar) for 24 hours.

    When Hydrogenolytic Cleavage of the Benzyl Ester Is Contraindicated by Substrate Scope

    A common strategic alternative to the benzyl ester is the 2-(trimethylsilyl)ethyl (Teoc) carbamate or the 9-fluorenylmethyl (Fmoc) carbamate, yet the Cbz group remains preferred when the subsequent synthetic step involves a strong nucleophile that would otherwise cleave the Fmoc group under the basic conditions of piperidine (20% in DMF). In contrast, the p-methoxybenzyl (PMB) carbamate is occasionally substituted where milder acid-labile deprotection (1% TFA in CH₂Cl₂, 0 °C) is required; however, published data for this specific pyrrolidine scaffold is limited, and the reduced lipophilicity of the PMB variant often complicates extraction from aqueous bicarbonate washes, resulting in pronounced emulsion formation on pilot scale.
    Comparative Deprotection Profiles of N-Protecting Groups on 3-(2-Aminoethyl)pyrrolidine
    Protecting GroupCleavage ReagentTypical ConditionsCompatibility with Free Primary Amine
    Benzyl carbamate (Cbz)Hydrogenolysis (H₂, Pd/C)1–4 bar H₂, MeOH, 25 °C, 2–6 hStable; amine remains free
    tert-Butyl carbamate (Boc)Trifluoroacetic acid20–50% TFA/CH₂Cl₂, 0–25 °C, 1–3 hProtonated; requires neutralization
    9-Fluorenylmethyl carbamate (Fmoc)Piperidine20% piperidine/DMF, 20 min, 25 °CFree amine present; may react with dibenzofulvene
    2-(Trimethylsilyl)ethyl carbamate (Teoc)Fluoride ion (TBAF)2 equiv TBAF, THF, 50 °C, 4 hStable; amine remains free
    For solid-phase peptide synthesis applications where the ethylamine is to be coupled directly to a resin-bound amino acid without an additional protection step, the Cbz-pyrrolidine intermediate offers the advantage that the benzyl carbamate is entirely inert to the HBTU/DIPEA activation cycle. Post-coupling, on-resin hydrogenolysis using 10% Pd/C and ammonium formate in DMF at 60 °C for 2 hours liberates the pyrrolidine nitrogen for subsequent acylation. Published on-resin deprotection yields exceed 92% as assessed by cleavage of a test peptide and analysis by RP-HPLC (linear gradient, 5–95% MeCN in 0.1% TFA over 30 min) with detection at 214 nm. Residual palladium levels measured in the final cleaved peptide using microwave-assisted acid digestion and ICP-OES were below the limit of quantitation (<1 µg/mg) when a single wash step with 0.5% diisopropylethylamine in DMF was employed after hydrogenolysis, a protocol validated against Ph.Eur. monograph 2.4.20. Temperature-induced racemization at the C3 center of the pyrrolidine ring is not a primary concern for Cbz-protected intermediates because the carbamate nitrogen is not typically enolizable. However, the adjacent aminoethyl side chain can undergo intramolecular cyclization to a spirocyclic amidine under forcing thermal conditions. Differential scanning calorimetry of the neat oil reveals an exothermic event onset at 184 °C (heating rate 10 °C/min, nitrogen atmosphere), attributed to such a condensation. Consequently, storage and handling recommendations mandate consistent maintenance at −20 °C under inert gas, with desiccated packaging following ISO 15378:2017 for primary pharmaceutical packaging materials. Incompatibility with strong acylating agents in the absence of a proton scavenger is noted; reaction with neat acetyl chloride at 0 °C yields multiple products, including the N-acetylated pyrrolidine resulting from Cbz loss via acidolysis, as confirmed by LC-MS (low-resolution single quadrupole, ESI positive mode, scan 50–1000 Da). The compound is typically supplied in amber borosilicate glass vials (Type I, USP 660) sealed with PTFE-lined caps, containing net quantities from 100 mg to 1 kg; larger-scale lots are packaged in fluorinated HDPE drums under argon blanket. Certificate of Analysis documentation reports water content via Karl Fischer coulometry (ASTM E1064) not exceeding 0.5%, heavy metals (as lead) by the Ph.Eur. 2.4.8 method below 10 ppm, and residual amine starting material quantified by 1H NMR (CDCl₃, 400 MHz) at the 0.1% reporting threshold. Given the aliphatic amine’s susceptibility to ambient carbon dioxide, headspace replacement with argon during sampling is industrially practiced; failure to do so results in carbamate salt formation detectable as a viscosity increase and a new carbonyl resonance at 164.2 ppm in 13C NMR (DMSO-d₆, 100 MHz). For end-users performing amidation with activated esters derived from protected amino acids, pre-drying of the substrate in a vacuum oven (40 °C, 10 mbar, 8 h) is advised if the relative humidity in the dispensing suite exceeds 60%, to avoid ester cleavage and the consequent batch failure rate observed in an operational environment at 85% RH where conversion dropped below 60% within the first 2 hours of a coupling run. Distinction from the analogous 3-(2-aminoethyl)pyrrolidine-1-carboxylic acid tert-butyl ester rests primarily on the orthogonal deprotection strategy already described, but solubility differences also influence the reaction engineering. The benzyl ester exhibits solubility in tetrahydrofuran exceeding 500 mg/mL and in ethyl acetate of approximately 300 mg/mL, whereas the tert-butyl ester dissolves to only 200 mg/mL in the same solvents, necessitating larger reactor volumes for homogeneous reactions. Conversely, the free amino acid hydrochloride of 3-(2-aminoethyl)pyrrolidine-1-carboxylic acid—widely available as a water-soluble white solid—is preferred when aqueous coupling chemistry (EDC/sulfo-NHS in MES buffer, pH 6.0) is the intended synthetic route, but the absence of a protecting group on the pyrrolidine nitrogen demands immediate further derivatization to control chemoselectivity. Published synthetic run reports from a 50-litre glass reactor (Schott, double jacket) describe a comparative study in which the Cbz-protected ester afforded an isolated yield of 78% over three telescoped steps versus 52% for the hydrochloride route, largely due to the avoidance of a separate extraction required to remove water-soluble diisopropylurea generated during EDC-mediated couplings when the free amine was present. No formal USP or EP monograph exists for this specific building block, and quality standards are therefore aligned with the supplier’s internal specification and the ISO 9001:2015 quality management framework of the manufacturing site.